Literature DB >> 27040070

Early combined treatment with steroid and immunoglobulin is effective for serious Kawasaki disease complicated by myocarditis and encephalopathy.

Kenichi Suga1, Miki Inoue, Akemi Ono, Tomomasa Terada, Masami Kawahito, Kazuhiro Mori.   

Abstract

Severe-type Kawasaki disease (KD) complicated by serious myocarditis and encephalopathy can be successfully treated without abnormality of the coronary arteries by steroid pulse treatment and intravenous immunoglobulin (IVIg). A 4-year-old Japanese girl was diagnosed with KD due to a 6-day history of fever, rash, flushed lips, conjunctival hyperemia, palmar edema, and cervical lymphadenopathy. The day after initiation of IVIg and aspirin, cardiac gallop rhythm was identified. Cardiac ultrasonography revealed severe left ventricular dysfunction. Disturbance of consciousness, hallucinations, and slurred speech were also observed. Magnetic resonance imaging showed no abnormalities, but electroencephalography revealed high-voltage slow waves. Despite this serious disease, cardiac function and neurological abnormalities showed complete recovery without dilatation of the coronary arteries by steroid pulse treatment and additional IVIg. Follow-up at 15 months revealed no abnormality of the coronary arteries. In conclusion, we suggest that early combined treatment with steroid and IVIg is effective for serious KD complicated by myocarditis and encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27040070     DOI: 10.2152/jmi.63.140

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  4 in total

1.  Early Desquamating Perineal Erythema in a Febrile Infant: A Characteristic Clinical Feature of Kawasaki Disease.

Authors:  Chiara Isidori; Lisa Sebastiani; Maria Chiara Cardellini; Giuseppe Di Cara; Donato Rigante; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2017-06-30       Impact factor: 3.390

2.  A Combination Therapy for Kawasaki Disease with Severe Complications: a Case Report.

Authors:  Yuriko Abe; Mamoru Ayusawa; Kengo Kawamura; Ryuta Yonezawa; Masataka Kato; Akiko Komori; Ryutaro Kohira; Ichiro Morioka
Journal:  Open Med (Wars)       Date:  2019-12-26

Review 3.  Multisystem Inflammatory Syndrome in Children (MIS-C).

Authors:  Julisa M Patel
Journal:  Curr Allergy Asthma Rep       Date:  2022-03-22       Impact factor: 4.919

4.  Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.

Authors:  Vladislav Vukomanovic; Stasa Krasic; Sergej Prijic; Sanja Ninic; Sasa Popovic; Gordana Petrovic; Snezana Ristic; Radoje Simic; Ivana Cerovic; Dejan Nesic
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.